Researchers at The Florey and Austin Health have made a significant breakthrough in Parkinson’s disease research, showing that it’s possible to identify the disease’s signs 20-30 years before symptoms emerge.
This discovery paves the way for early screening programs and preventive treatments, potentially preventing the irreversible brain damage typically seen in later stages.
Understanding Parkinson’s Disease: A Midlife Onset
Contrary to common perception, Parkinson’s disease often begins in midlife, remaining undetected for decades.
Professor Kevin Barnham from Florey explains that by the time symptoms become apparent, up to 85% of the brain’s motor-control neurons may already be destroyed, rendering many treatments ineffective. This highlights the crucial need for early detection.
The Study: Advancements in Diagnosis Using F-AV-133 and PET Scans
Published in Neurology, the study led by Professor Barnham utilized a biomarker called F-AV-133 in conjunction with positron emission tomography (PET) scans.
The Melbourne study involved scanning 26 Parkinson’s patients, a control group, and individuals with Rapid Eye Movement sleep behavior disorder (RBD), which often precedes Parkinson’s.
Key Findings: Tracking Neuronal Loss
Despite no significant clinical symptom changes in participants, PET scans revealed substantial neuronal loss in key brain areas.
This indicates that F-AV-133 combined with PET scans is a more sensitive method for monitoring neurodegeneration compared to current methods.
Mathematical modeling estimated a total of 33 years of slow neuronal loss, occurring for about 22.5 years before symptoms are sufficient for diagnosis.
These findings are groundbreaking, potentially allowing for the diagnosis and treatment of Parkinson’s disease up to a decade earlier than currently possible. This could transform patient outcomes and assist in identifying candidates for clinical trials.
Understanding Rapid Eye Movement Behavioural Disorder (RBD)
RBD is a condition where individuals physically act out vivid and often unpleasant dreams due to a lack of muscle paralysis during sleep. It is a significant early warning sign for Parkinson’s disease, with 90% of RBD patients likely to develop a parkinsonian condition.
Recognizing and addressing RBD through consultation with sleep specialists and neurologists could be key in early Parkinson’s disease intervention.
Moving Forward: A Hopeful Future for Parkinson’s Patients
This research represents a hopeful future for individuals at risk of Parkinson’s disease, offering a chance for early intervention and potentially altering the course of this debilitating condition.
With continued research and development, the possibility of screening programs and preventative treatments becomes a promising reality.
If you care about brain health, please read studies about The blood pressure numbers and your brain health and The future of Parkinson’s prediction: it’s in your blood and brain.
For more information about Parkinson’s disease, please see recent studies about Keto diet as a potential aid for Parkinson’s disease and results showing that Flavonoids in diet may lower death risk in Parkinson’s disease.
The research findings can be found in Neurology.
Copyright © 2023 Knowridge Science Report. All rights reserved.
